LPX-TI641

· LAPIX Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LPX-TI641, covering 2025-01-23 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis [Phase 1]